TRex Bio

TRXB · NASDAQ

$14.70−$0.10 (−0.68%)TodayMarket open · Oct 20, 2:10 PM ET · Delayed 15 min

Prev close $14.80

About TRXB

TRex Bio, Inc. is a US-based company operating in industry. The company is headquartered in South San Francisco, California. The company went IPO on 2026-10-09. TRex Bio, Inc is a clinical-stage biopharmaceutical company focused on tissue Treg biology for the discovery and development of immunoregulatory medicines designed to restore immune balance and promote tissue repair to address unmet needs of patients with autoimmune and inflammatory diseases. The firm's Deep Biology platform decodes Treg functionality in human tissue, mapping key drivers of immune dysregulation and uncovering novel targets and insights that inform drug discovery and translational efforts. This platform has generated multiple therapeutic development candidates across its wholly owned pipeline and through collaborations with pharma partners. Its product candidate, TRB-061, is an investigational tumor necrosis factor receptor 2 (TNFR2) agonist designed to expand and activate Tregs in inflamed tissues. TRB-071 is an investigational CD30 agonist designed to both augment tissue Tregs and block an immune system inflammatory pathway.

Employees: 0
Headquarters: South San Francisco, California
Listed: Oct 9, 2026
Sector: N/A
Industry: N/A
Website: trex.bio

TRXB key statistics

Market cap: 406.20M
Price-earnings ratio: —
Dividend yield: —
Average volume: 357.42K
Volume: 31.07K
Open price: $14.80
High today: $15.01
Low today: $14.22
52 Week high: $15.50
52 Week low: $13.21

TRex Bio (TRXB) at a glance

As of Oct 20, 2026, TRex Bio (TRXB) shares are priced at $14.70, giving the company a market cap of 406.20M.

Today the stock has traded between $14.22 and $15.01. The current price is 3.4% above the day's low and 2.1% below its high.

Volume so far is 31.07K shares, below the average of 357.42K shares a day.

Over the past year TRex Bio has ranged from $13.21 to $15.50, and now sits 65% of the way up that range.

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.